000813.SZ · 德展健康
China A-shares · RS rating 36 · As of 2026-10-14
| Price | 3.19 CNY |
|---|---|
| 1-day change | -1.2% |
| RS rating (overall / 1M / 3M / 12M) | 36 / 16 / 54 / 29 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 28 / 20 / 29 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -39.1% |
| Distance from 52-week high | +30.5% |
| Market cap (USD) | $1.0B |